Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Ophthalmology Science|December 26, 2023
Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein OcclusionDaisuke Nagasato, Yuki Muraoka, Mao Tanabe, et al.Scientific Reports|November 13, 2020
Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusionDaisuke Nagasato, Yuki Muraoka, Rie Osaka, et al.Ophthalmology. Retina|February 26, 2022
Foveal Thickness Fluctuation in Anti-VEGF Treatment for Branch Retinal Vein Occlusion: A Long-term StudyDaisuke Nagasato, Yuki Muraoka, Mao Tanabe, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 23, 2016
Cotton Wool Spots after Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Central Retinal Vein OcclusionTeruyo Kida, Akitaka Tsujikawa, Yuki Muraoka, et al.Scientific Reports|May 10, 2022
Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatmentToshinori Murata, Mineo Kondo, Makoto Inoue, et al.Scientific Reports|January 13, 2021
The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patientsToshinori Murata, Mineo Kondo, Makoto Inoue, et al.Journal of Clinical Medicine|November 26, 2022
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in JapanRyohei Komori, Yoshihiro Takamura, Yutaka Yamada, et al.Retina (Philadelphia, Pa.)|October 18, 2024
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 StudyMasahiko Shimura, Takao Hirano, Eiko Tsuiki, et al.Pageof 3